Swedbank’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $249M | Sell |
|
|||||
|
2021
Q1 | $213M | Sell |
|
|||||
|
2020
Q4 | $334M | Sell |
|
|||||
|
2020
Q3 | $300M | Sell |
|
|||||
|
2020
Q2 | $295M | Sell |
|
|||||
|
2020
Q1 | $310M | Buy |
|
|||||
|
2019
Q4 | $343M | Buy |
|
|||||
|
2019
Q3 | $260M | Buy |
|
|||||
|
2019
Q2 | $187M | Buy |
|
|||||
|
2019
Q1 | $98.9M | Sell |
|
|||||
|
2018
Q4 | $83.7M | Buy |
|
|||||
|
2018
Q3 | $81.7M | Sell |
|
|||||
|
2018
Q2 | $102M | Buy |
|